Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Xmab-541 by Xencor for Peritoneal Cancer: Likelihood of Approval
Xmab-541 is under clinical development by Xencor and currently in Phase I for Peritoneal Cancer. According to GlobalData, Phase I...
Xmab-541 by Xencor for Metastatic Ovarian Cancer: Likelihood of Approval
Xmab-541 is under clinical development by Xencor and currently in Phase I for Metastatic Ovarian Cancer. According to GlobalData, Phase...
Xmab-541 by Xencor for Fallopian Tube Cancer: Likelihood of Approval
Xmab-541 is under clinical development by Xencor and currently in Phase I for Fallopian Tube Cancer. According to GlobalData, Phase...
Xmab-541 by Xencor for Uterine Cancer: Likelihood of Approval
Xmab-541 is under clinical development by Xencor and currently in Phase I for Uterine Cancer. According to GlobalData, Phase I...
Xmab-541 by Xencor for Endometrial Cancer: Likelihood of Approval
Xmab-541 is under clinical development by Xencor and currently in Phase I for Endometrial Cancer. According to GlobalData, Phase I...